The Influence of Vitamin D Levels and Supplementation on the Treatment of Patients Affected by MRONJ

<b>Background:</b> Advancements in pharmacology have led to the introduction of novel antiresorptive and antiangiogenic drugs, which are associated with the side effect of medication-related osteonecrosis of the jaw (MRONJ). The aim of this study was to evaluate the impact of different b...

Full description

Saved in:
Bibliographic Details
Main Authors: Filip Michalak, Marzena Dominiak, Jan Kiryk, Paweł Popecki, Dominik Kubicki, Jacek Matys, Kinga Grzech-Leśniak
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Applied Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3417/15/2/670
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832589231928639488
author Filip Michalak
Marzena Dominiak
Jan Kiryk
Paweł Popecki
Dominik Kubicki
Jacek Matys
Kinga Grzech-Leśniak
author_facet Filip Michalak
Marzena Dominiak
Jan Kiryk
Paweł Popecki
Dominik Kubicki
Jacek Matys
Kinga Grzech-Leśniak
author_sort Filip Michalak
collection DOAJ
description <b>Background:</b> Advancements in pharmacology have led to the introduction of novel antiresorptive and antiangiogenic drugs, which are associated with the side effect of medication-related osteonecrosis of the jaw (MRONJ). The aim of this study was to evaluate the impact of different blood levels of vitamin D on the course of treatment, as well as the role of vitamin D supplementation during the treatment of primary diseases involving bisphosphonates or denosumab. Methods: The clinical trial involved 64 patients diagnosed with medication-related osteonecrosis of the jaw (MRONJ) treated at the Department of Oral Surgery. Participants underwent baseline panoramic radiographs and Cone Beam Computed Tomography (CBCT) scans, with MRONJ severity categorized according to the AAOMS classification. This study included two groups: 37 patients (n = 37) in the experimental group received high-dose vitamin D supplementation (10,000 IU/day for 4 weeks, followed by a maintenance dose of 5000 IU/day), while 27 patients (n = 27) in the control group received no supplementation. Vitamin D levels were measured at baseline, 3 months, and 6 months, and the relationship between vitamin D supplementation and clinical outcomes, including MRONJ risk and healing, was evaluated. All participants received an antibiotic regimen pre- and post-surgery. Pain intensity was assessed at multiple time points using the Visual Analog Scale (VAS). Results: This study showed significant increases in serum vitamin D levels in the experimental group at 3 and 6 months (<i>p</i> < 0.05). In the prophylactic context, Vitamin D supplementation prior to or during tooth extraction reduced the risk of developing severe MJRON (OR = 68.57; <i>p</i> < 0.001). In the therapeutic context among patients with established MJRON, vitamin D supplementation did not significantly predict postoperative complications (<i>p</i> = 0.079) or complete healing (OR = 2.34; <i>p</i> = 0.051). However, overall healing rates were somewhat higher in the supplemented group, though they did not reach statistical significance. Antibiotic protection uses also reduced the need for further treatment (OR = 6.20; <i>p</i> < 0.001). Conclusions: Prophylactic high-dose vitamin D supplementation may help prevent severe MRONJ in at-risk patients undergoing tooth extraction. Once MRONJ is established, however, vitamin D alone may not significantly alter immediate postoperative outcomes, although further research is needed to clarify its potential adjunctive benefits.
format Article
id doaj-art-02997712744c42e19d98b0328c38203e
institution Kabale University
issn 2076-3417
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Applied Sciences
spelling doaj-art-02997712744c42e19d98b0328c38203e2025-01-24T13:20:22ZengMDPI AGApplied Sciences2076-34172025-01-0115267010.3390/app15020670The Influence of Vitamin D Levels and Supplementation on the Treatment of Patients Affected by MRONJFilip Michalak0Marzena Dominiak1Jan Kiryk2Paweł Popecki3Dominik Kubicki4Jacek Matys5Kinga Grzech-Leśniak6Dental Surgery Department, Wroclaw Medical University, Krakowska St. 26, 50-425 Wroclaw, PolandDental Surgery Department, Wroclaw Medical University, Krakowska St. 26, 50-425 Wroclaw, PolandDental Surgery Department, Wroclaw Medical University, Krakowska St. 26, 50-425 Wroclaw, PolandDental Surgery Department, Wroclaw Medical University, Krakowska St. 26, 50-425 Wroclaw, PolandClinical Department of Pediatric Nephrology, Wroclaw Medical University, Borowska Street 213, 50-556 Wroclaw, PolandDental Surgery Department, Wroclaw Medical University, Krakowska St. 26, 50-425 Wroclaw, PolandDental Surgery Department, Wroclaw Medical University, Krakowska St. 26, 50-425 Wroclaw, Poland<b>Background:</b> Advancements in pharmacology have led to the introduction of novel antiresorptive and antiangiogenic drugs, which are associated with the side effect of medication-related osteonecrosis of the jaw (MRONJ). The aim of this study was to evaluate the impact of different blood levels of vitamin D on the course of treatment, as well as the role of vitamin D supplementation during the treatment of primary diseases involving bisphosphonates or denosumab. Methods: The clinical trial involved 64 patients diagnosed with medication-related osteonecrosis of the jaw (MRONJ) treated at the Department of Oral Surgery. Participants underwent baseline panoramic radiographs and Cone Beam Computed Tomography (CBCT) scans, with MRONJ severity categorized according to the AAOMS classification. This study included two groups: 37 patients (n = 37) in the experimental group received high-dose vitamin D supplementation (10,000 IU/day for 4 weeks, followed by a maintenance dose of 5000 IU/day), while 27 patients (n = 27) in the control group received no supplementation. Vitamin D levels were measured at baseline, 3 months, and 6 months, and the relationship between vitamin D supplementation and clinical outcomes, including MRONJ risk and healing, was evaluated. All participants received an antibiotic regimen pre- and post-surgery. Pain intensity was assessed at multiple time points using the Visual Analog Scale (VAS). Results: This study showed significant increases in serum vitamin D levels in the experimental group at 3 and 6 months (<i>p</i> < 0.05). In the prophylactic context, Vitamin D supplementation prior to or during tooth extraction reduced the risk of developing severe MJRON (OR = 68.57; <i>p</i> < 0.001). In the therapeutic context among patients with established MJRON, vitamin D supplementation did not significantly predict postoperative complications (<i>p</i> = 0.079) or complete healing (OR = 2.34; <i>p</i> = 0.051). However, overall healing rates were somewhat higher in the supplemented group, though they did not reach statistical significance. Antibiotic protection uses also reduced the need for further treatment (OR = 6.20; <i>p</i> < 0.001). Conclusions: Prophylactic high-dose vitamin D supplementation may help prevent severe MRONJ in at-risk patients undergoing tooth extraction. Once MRONJ is established, however, vitamin D alone may not significantly alter immediate postoperative outcomes, although further research is needed to clarify its potential adjunctive benefits.https://www.mdpi.com/2076-3417/15/2/670ARDbisphosphonatesdenosumabMRONJosteonecrosisvitamin D
spellingShingle Filip Michalak
Marzena Dominiak
Jan Kiryk
Paweł Popecki
Dominik Kubicki
Jacek Matys
Kinga Grzech-Leśniak
The Influence of Vitamin D Levels and Supplementation on the Treatment of Patients Affected by MRONJ
Applied Sciences
ARD
bisphosphonates
denosumab
MRONJ
osteonecrosis
vitamin D
title The Influence of Vitamin D Levels and Supplementation on the Treatment of Patients Affected by MRONJ
title_full The Influence of Vitamin D Levels and Supplementation on the Treatment of Patients Affected by MRONJ
title_fullStr The Influence of Vitamin D Levels and Supplementation on the Treatment of Patients Affected by MRONJ
title_full_unstemmed The Influence of Vitamin D Levels and Supplementation on the Treatment of Patients Affected by MRONJ
title_short The Influence of Vitamin D Levels and Supplementation on the Treatment of Patients Affected by MRONJ
title_sort influence of vitamin d levels and supplementation on the treatment of patients affected by mronj
topic ARD
bisphosphonates
denosumab
MRONJ
osteonecrosis
vitamin D
url https://www.mdpi.com/2076-3417/15/2/670
work_keys_str_mv AT filipmichalak theinfluenceofvitamindlevelsandsupplementationonthetreatmentofpatientsaffectedbymronj
AT marzenadominiak theinfluenceofvitamindlevelsandsupplementationonthetreatmentofpatientsaffectedbymronj
AT jankiryk theinfluenceofvitamindlevelsandsupplementationonthetreatmentofpatientsaffectedbymronj
AT pawełpopecki theinfluenceofvitamindlevelsandsupplementationonthetreatmentofpatientsaffectedbymronj
AT dominikkubicki theinfluenceofvitamindlevelsandsupplementationonthetreatmentofpatientsaffectedbymronj
AT jacekmatys theinfluenceofvitamindlevelsandsupplementationonthetreatmentofpatientsaffectedbymronj
AT kingagrzechlesniak theinfluenceofvitamindlevelsandsupplementationonthetreatmentofpatientsaffectedbymronj
AT filipmichalak influenceofvitamindlevelsandsupplementationonthetreatmentofpatientsaffectedbymronj
AT marzenadominiak influenceofvitamindlevelsandsupplementationonthetreatmentofpatientsaffectedbymronj
AT jankiryk influenceofvitamindlevelsandsupplementationonthetreatmentofpatientsaffectedbymronj
AT pawełpopecki influenceofvitamindlevelsandsupplementationonthetreatmentofpatientsaffectedbymronj
AT dominikkubicki influenceofvitamindlevelsandsupplementationonthetreatmentofpatientsaffectedbymronj
AT jacekmatys influenceofvitamindlevelsandsupplementationonthetreatmentofpatientsaffectedbymronj
AT kingagrzechlesniak influenceofvitamindlevelsandsupplementationonthetreatmentofpatientsaffectedbymronj